These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27217240)

  • 1. Role of Serum cartilage oligomeric matrix protein (COMP) in the diagnosis of rheumatoid arthritis (RA): A case-control study.
    Liu F; Wang X; Zhang X; Ren C; Xin J
    J Int Med Res; 2016 Aug; 44(4):940-9. PubMed ID: 27217240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early diagnostic and prognostic values of anti-cyclic citrullinated peptide antibody and cartilage oligomeric matrix protein in rheumatoid arthritis.
    Algergawy SA; Abd El-Sabour M; Osman AS; Emam SM; Elham N
    Egypt J Immunol; 2013; 20(2):11-20. PubMed ID: 24617043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritis.
    Christensen AF; Lindegaard H; Hørslev-Petersen K; Hetland ML; Ejbjerg B; Stengaard-Pedersen K; Jacobsen S; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Tarp U; Pødenphant J; Østergaard M; Junker P
    J Rheumatol; 2011 Aug; 38(8):1563-8. PubMed ID: 21572145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and its correlation with sonographic knee cartilage thickness and disease activity.
    Sakthiswary R; Rajalingam S; Hussein H; Sridharan R; Asrul AW
    Clin Rheumatol; 2017 Dec; 36(12):2683-2688. PubMed ID: 28889184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and synovial cartilage oligomeric matrix protein levels in early and established rheumatoid arthritis.
    El Defrawy AO; Gheita TA; Raslan HM; El Ansary MM; El Awar AH
    Z Rheumatol; 2016 Nov; 75(9):917-923. PubMed ID: 26683321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity.
    Söderlin MK; Kastbom A; Kautiainen H; Leirisalo-Repo M; Strandberg G; Skogh T
    Scand J Rheumatol; 2004; 33(3):185-8. PubMed ID: 15228190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
    Chang PY; Yang CT; Cheng CH; Yu KH
    Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMP-C3b complexes in rheumatoid arthritis with severe extraarticular manifestations.
    Happonen KE; Saxne T; Jacobsson L; Sturfelt G; Rönnelid J; Mollnes TE; Heinegård D; Turesson C; Blom AM
    J Rheumatol; 2013 Dec; 40(12):2001-5. PubMed ID: 24187101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic impact of contemporary biomarker assays for rheumatoid arthritis.
    Nikolaisen C; Rekvig OP; Nossent HC
    Scand J Rheumatol; 2007; 36(2):97-100. PubMed ID: 17476614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatment.
    Skoumal M; Haberhauer G; Feyertag J; Kittl EM; Bauer K; Dunky A
    Rheumatol Int; 2006 Sep; 26(11):1001-4. PubMed ID: 16485108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis.
    Morozzi G; Fabbroni M; Bellisai F; Cucini S; Simpatico A; Galeazzi M
    Clin Rheumatol; 2007 Aug; 26(8):1335-8. PubMed ID: 17285224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of the anti-Sa antibody compared with the anti-cyclic citrullinated peptide antibody in rheumatoid arthritis.
    Iwaszkiewicz C; Puszczewicz M; Białkowska-Puszczewicz G
    Int J Rheum Dis; 2015 Jan; 18(1):46-51. PubMed ID: 25488711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between cartilage oligomeric matrix protein (COMP) and rheumatoid arthritis severity.
    Saghafi M; Khodashahi M; Saadati N; Azarian A; Rezaieyazdi Z; Salehi M; Sahebari M
    Electron Physician; 2017 Dec; 9(12):5940-5947. PubMed ID: 29560145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis.
    Skoumal M; Kolarz G; Klingler A
    Scand J Rheumatol; 2003; 32(3):156-61. PubMed ID: 12892252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic value of serum anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis].
    Yang CL; Zhou YR; Zhou F; Li J
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1277-9. PubMed ID: 17715048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
    Maraina CH; Nurdayana AK; Rusni D; Azwany Y
    Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of a fluorescence immunochromatography for quantitative detection of cartilage oligomeric matrix protein].
    Zhang Y; Wang Y; Wang J; Li Y; Wang X; Wang X
    Sheng Wu Gong Cheng Xue Bao; 2022 Jun; 38(6):2332-2341. PubMed ID: 35786483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to Cartilage Oligomeric Matrix Protein Are Pathogenic in Mice and May Be Clinically Relevant in Rheumatoid Arthritis.
    Ge C; Tong D; Lönnblom E; Liang B; Cai W; Fahlquist-Hagert C; Li T; Kastbom A; Gjertsson I; Dobritzsch D; Holmdahl R
    Arthritis Rheumatol; 2022 Jun; 74(6):961-971. PubMed ID: 35080151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
    Fujikawa K; Kawakami A; Tamai M; Uetani M; Takao S; Arima K; Iwamoto N; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
    J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of cartilage oligomeric matrix protein (COMP) and a COMP neoepitope in synovial fluid of patients with different joint disorders by novel automated assays.
    Lorenzo P; Aspberg A; Saxne T; Önnerfjord P
    Osteoarthritis Cartilage; 2017 Sep; 25(9):1436-1442. PubMed ID: 28473207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.